Vertaling van "first trial " (Nederlands → Frans) :

TERMINOLOGIE

first-pass | eerste hindernis
?

IN-CONTEXT TRANSLATIONS

The first trial in the US is now expected to begin in Virginia in June 2010 after a case was dismissed that had been scheduled for trial in Louisiana in January 2010.
Le premier procès aux Etats- Unis est prévu en juin 2010 en Virginie, après que la Louisiane eut rejeté une plainte dont le procès devait commencer en janvier 2010.

The first trial in the US is expected to begin in Virginia in June 2010.
Le premier procès aux Etats- Unis est prévu en juin 2010 en Virginie.

The first trial in the US, which was expected to begin in Virginia in June 2010, has therefore been postponed.
Par conséquent, le premier procès aux Etats-Unis, qui devait débuter en juin 2010 en Virginie, a été repoussé.

In the course of 2008 there were at least another 99 early phase trials of which 43 trials being carried out for the first time in humans, 164 phase I trials (including those not falling under the definition of an early phase trial), 176 phase II trials and 223 phase III trials. The database currently does not always allow a distinction to be made between early phase trials as defined above and later phases.
In the course of 2008 there were at least another 99 early phase trials of which 43 trials being carried out for the first time in humans, 164 phase I trials (including those not falling under the definition of an early phase trial), 176 phase II trials and 223 phase III trials. The database currently does not always allow a distinction to be made between early phase trials as defined above and later phases.

ASA404 Non-small cell lung cancer (NSCLC) 2012 III - First-line Phase III NSCLC trial stopped in March 2010, secondline Phase III NSCLC trial ongoing (interim analysis in H2 2010)
DEB025 Hépatite C ≥ 2014 II - Sous licence de Debiopharm au T1 2010 EPO906 Cancer ovarien 2010 III - En voie d’être soumis en 2010 Exjade Thalassémie nontransfusion dépendante 2011 II

o Significant innovation momentum underpinned by FDA approval of Gilenya as first-inclass novel therapy for relapsing multiple sclerosis; Tasigna received positive CHMP opinion and approval in Switzerland as first-line therapy; positive Phase III trial data for Onbrez over salmeterol and positive Phase III data for MenB
o Accélération importante de l’innovation, soutenue par l’homologation par la FDA de Gilenya, un nouveau traitement, premier de sa classe, contre la sclérose en plaques cyclique; Tasigna a obtenu un préavis favorable du CHMP et a été autorisé en Suisse comme traitement de première ligne; résultats positifs d’un essai de phase III pour Onbrez comparé à salmétérol et bons résultats de phase III pour MenB

Trials are currently scheduled to begin in Louisiana and Virginia in the first quarter of 2010.
Il est prévu que des procès commencent au premier trimestre 2010 en Louisiane et en Virginie.

After a first selection based on title and abstract, 4 trials 43-46 were selected and 241 excluded.
After a first selection based on title and abstract, 4 trials 45-48 were selected and 241 excluded.

The R&D (research and development) department of the FAMHP is responsible for the evaluation and approval of clinical research activities, ranging from the first “use” (concept) to extensive trials with medicines that are developed and carried out by university and other research centres and by the pharmaceutical industry.
The R&D (research and development) department of the FAMHP is responsible for the evaluation and approval of clinical research activities, ranging from the first “use” (concept) to extensive trials with medicines that are developed and carried out by university and other research centres and by the pharmaceutical industry.

SOM230 became the first medical therapy to show efficacy in treating Cushing's disease in a Phase III trial.
SOM230 est devenu le premier traitement médical à avoir montré son efficacité dans la maladie de Cushing lors d’un essai de phase III. La maladie de Cushing est une perturbation invalidante du système endocrinien pour laquelle il n’existe actuellement aucun médicament autorisé.